Fig. 3From: Evaluation of calprotectin and ischemia-modified albumin serum levels as biomarkers to measure disease activity in Behçet’s diseaseROC curve analysis for the ability of the IMA serum level to discriminate between patients with active and inactive BD (AUC = 0.738)Back to article page